3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide

C27H31F3N4O — CID 67082091

IUPAC3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide
SMILESCc1nc2ccccc2n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CC(F)(F)F)c1ccccc1
InChIInChI=1S/C27H31F3N4O/c1-18-31-24-9-5-6-10-25(24)34(18)22-15-20-11-12-21(16-22)33(20)14-13-23(19-7-3-2-4-8-19)32-26(35)17-27(28,29)30/h2-10,20-23H,11-17H2,1H3,(H,32,35)/t20?,21?,22?,23-/m0/s1
InChIKeyZSEDQINSVQNSGQ-JVLTXYAPSA-N
MW484.57 g/mol
LogP5.71
Rot. Bonds7

About 3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide

3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide (PubChem CID 67082091) has the molecular formula C27H31F3N4O and a molecular weight of 484.57 g/mol. Its IUPAC name is 3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide.

Molecular Properties

Compound Name3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide
PubChem CID67082091
Molecular FormulaC27H31F3N4O
Molecular Weight484.57 g/mol
Exact Mass484.24
IUPAC Name3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide
SMILESCc1nc2ccccc2n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CC(F)(F)F)c1ccccc1
InChIInChI=1S/C27H31F3N4O/c1-18-31-24-9-5-6-10-25(24)34(18)22-15-20-11-12-21(16-22)33(20)14-13-23(19-7-3-2-4-8-19)32-26(35)17-27(28,29)30/h2-10,20-23H,11-17H2,1H3,(H,32,35)/t20?,21?,22?,23-/m0/s1
InChIKeyZSEDQINSVQNSGQ-JVLTXYAPSA-N
XLogP5.71
TPSA50.16 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds7
Heavy Atoms35
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500484.57
LogP ≤ 55.71
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze 3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide?
The IUPAC name of 3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide (CID 67082091) is 3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide.
What is the SMILES notation for 3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide?
The canonical SMILES for 3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide is Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CC(F)(F)F)c1ccccc1.
What is the InChIKey of 3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide?
The InChIKey is ZSEDQINSVQNSGQ-JVLTXYAPSA-N. The full InChI is InChI=1S/C27H31F3N4O/c1-18-31-24-9-5-6-10-25(24)34(18)22-15-20-11-12-21(16-22)33(20)14-13-23(19-7-3-2-4-8-19)32-26(35)17-27(28,29)30/h2-10,20-23H,11-17H2,1H3,(H,32,35)/t20?,21?,22?,23-/m0/s1.
What are the key properties of 3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide?
3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide has a molecular weight of 484.57 g/mol, XLogP of 5.71, 7 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 3,3,3-trifluoro-N-[(1S)-3-[3-(2-methylbenzimidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]propanamide is sourced from PubChem (CID 67082091), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).